| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VAPOTHERM Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,760 | +0,43 % | AT&S: Neuer Vorstand mit Fresenius-Erfahrung | Der Aufsichtsrat von AT&S beruft ein neues Vorstandsmitglied. Gerrit Steen wird den Vorstand der Gesellschaft zum 1. Februar 2026 verstärken. Der wird dann den Posten des CFO übernehmen. Steen war zuletzt... ► Artikel lesen | |
| MEDTRONIC | 82,47 | -0,70 % | Dividendenbekanntmachungen (26.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1782 EUR ALTRIA GROUP INC US02209S1033 1,06 USD 0,8999 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| INTUITIVE SURGICAL | 489,40 | -0,88 % | Is ISRG's 20% Procedure Growth the New Normal or a Peak? | ||
| THERMO FISHER | 491,15 | +1,76 % | Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 | ||
| ROKU | 92,81 | -2,10 % | Nielsen To Incorporate Roku's Data Into Its Advanced Campaign Measurement And Outcome Solutions | WASHINGTON (dpa-AFX) - Nielsen, a global data, analytics, and audience measurement company, has expanded its long-term strategic partnership with Roku, Inc. (ROKU) to incorporate the latter's... ► Artikel lesen | |
| BECTON DICKINSON | 166,05 | -0,36 % | BD faces hernia mesh lawsuit from Tela Bio | ||
| DEXCOM | 56,63 | -1,29 % | DEXCOM INC - 8-K, Current Report | ||
| BOSTON SCIENTIFIC | 81,60 | +0,74 % | A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook | ||
| RESMED | 208,40 | 0,00 % | Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort | WASHINGTON (dpa-AFX) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed... ► Artikel lesen | |
| BAXTER | 15,504 | -0,84 % | Reasons to Retain Baxter International Stock in Your Portfolio Now | ||
| DAVITA | 97,24 | -1,68 % | DaVita: Balancing a Kidney Diet: Optimizing Nutrition Through Personalization | NORTHAMPTON, MA / ACCESS Newswire / December 22, 2025 / DaVita:For individuals managing chronic kidney disease (CKD), dietary choices significantly impact health outcomes and disease progression. A... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,600 | -0,83 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy | Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval
SEATTLE... ► Artikel lesen | |
| ZIMMER BIOMET | 76,00 | +0,08 % | Bactiguard Holding AB: Bactiguard announces updated trauma license agreement with Zimmer Biomet | Bactiguard continues the collaboration with Zimmer Biomet in an updated agreement, giving Zimmer Biomet non-exclusive rights to continue to commercialize the ZNN Bactiguard coated trauma nail system... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| TANDEM DIABETES | 19,550 | +4,55 % | Tandem Diabetes upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 |